Model‐Informed Drug Development: Bang for the Buck?
Clinical Pharmacology & Therapeutics · 2025-08 · 118 (2) · 283-287
DOI: 10.1002/cpt.3744 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 18.07.2025. Verfasst von Allison Dunn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
- Certara, Applied BioSimulation, Canterbury, UK.
- Leiden Academic Centre for Drug Research, Leiden, The Netherlands.
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Zitieren
APA
Dunn, A., & van der Graaf, P. H. (2025). Model‐Informed Drug Development: Bang for the Buck?. Clinical Pharmacology & Therapeutics, 118(2), 283-287. https://doi.org/10.1002/cpt.3744
Vancouver
Dunn A, van der Graaf PH. Model‐Informed Drug Development: Bang for the Buck?. Clinical Pharmacology & Therapeutics. 2025;118(2):283-287. doi:10.1002/cpt.3744
BibTeX
@article{Dunn2025,
author = {Dunn, Allison and van der Graaf, Piet H},
title = {Model‐Informed Drug Development: Bang for the Buck?},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
volume = {118},
number = {2},
pages = {283--287},
doi = {10.1002/cpt.3744}
}
EUVIMED